In a groundbreaking move, the Director General of Health Services, Dr. Atul Goel, has issued a directive to doctors, urging them to “mandatorily mention the exact indication/reason/justification while prescribing antimicrobials.” The directive, outlined in a letter addressed to doctors, emphasizes the crucial need for responsible antibiotic prescription to curb the misuse and overuse of antimicrobials, which have been identified as major contributors to the rise of drug-resistant pathogens.
Dr. Goel’s letter, dated January 1, also extends its reach to pharmacists, urging them to strictly adhere to Schedule H and H1 of the Drugs and Cosmetics Rules. The directive emphasizes the importance of selling antibiotics only on valid prescriptions, aiming to eliminate the over-the-counter sale of these crucial medications.
Antimicrobial Resistance (AMR) has become a global concern, prompting governments worldwide to take decisive actions. The misuse and overuse of antibiotics are recognized as primary drivers in the emergence of drug-resistant pathogens. Dr. Goel’s directive underscores the urgency of prudent antibiotic use, emphasizing that, with few new antibiotics in the Research & Development pipeline, responsible prescription practices are the key to delaying the development of resistance.
The government’s proactive measures align with international efforts to address the growing threat of AMR. By targeting both doctors and pharmacists, the directive aims to create a unified front against irresponsible antibiotic practices. The letter acknowledges the limited pipeline for new antibiotics, making it imperative to safeguard the efficacy of existing ones.
Pharmacists, in addition to halting the over-the-counter sale of antibiotics, are expected to play a pivotal role in ensuring that antibiotics are dispensed only with valid prescriptions. The directive not only serves as a regulatory measure but also as an educational tool, raising awareness among healthcare professionals about the critical role they play in mitigating the risks associated with AMR.
As the world grapples with the challenges posed by antimicrobial resistance, India’s bold step signifies a commitment to global health security. The government’s proactive approach is likely to set a precedent for other nations grappling with the complex issue of AMR, underlining the need for collective and coordinated efforts to preserve the effectiveness of antibiotics and combat the rise of drug-resistant infections.
Read Further : http://tinyurl.com/mwrm5ez5
